Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
25,15 SEK | +1,62% | +6,12% | +32,65% |
Attività
Numero di dipendenti: 109
Vendite per attività
SEK in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 326 | 100,0 % | 71 | 100,0 % | -78,09% |
Vendite per regione
SEK in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
66,3
%
| 273 | 83,8 % | 47 | 66,3 % | -82,66% |
Sweden
25,6
%
| 26 | 7,9 % | 18 | 25,6 % | -28,75% |
Europe
4,1
%
| 27 | 8,3 % | 3 | 4,1 % | -89,11% |
Other Countries
4,0
%
| - | - | 3 | 4,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Martin Welschof
CEO | Chief Executive Officer | 63 | 01/09/18 |
Stefan Ericsson
DFI | Director of Finance/CFO | 61 | 01/01/98 |
Marie Moores
COO | Chief Operating Officer | - | 01/02/22 |
Björn Frendéus
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/01/01 |
Chief Tech/Sci/R&D Officer | 68 | 01/01/17 | |
Investor Relations Contact | - | 01/02/21 | |
Emma Meurling
HRO | Human Resources Officer | - | - |
General Counsel | - | 12/06/23 | |
Corporate Officer/Principal | - | 09/06/22 | |
Corporate Officer/Principal | 50 | 01/01/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 01/01/18 |
Leonard Kruimer
CHM | Chairman | 66 | 12/05/16 |
Vincent Ossipow
BRD | Director/Board Member | 55 | 12/05/16 |
Thomas O. Hecht
BRD | Director/Board Member | 73 | 03/07/20 |
Erik Esveld
BRD | Director/Board Member | - | 29/04/21 |
Director/Board Member | 49 | 12/07/22 | |
Director/Board Member | 56 | 01/01/18 | |
Natalie Berner
BRD | Director/Board Member | 34 | 12/07/22 |
Martin Pålsson
BRD | Director/Board Member | 45 | 01/01/22 |
Elin Birgersson
BRD | Director/Board Member | 39 | 01/01/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 65 804 362 | 57 013 147 ( 86,64 %) | 0 | 86,64 % |
Coordinate società
BioInvent International AB
The Gamma Building Ideongatan 1
223 70, Lund
+46 4 62 86 85 50
http://www.bioinvent.comSettore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+32,65% | 151 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione BINV
- Società BioInvent International AB